CN118078719A - Wet tissue composition for eyes as well as preparation method and application thereof - Google Patents
Wet tissue composition for eyes as well as preparation method and application thereof Download PDFInfo
- Publication number
- CN118078719A CN118078719A CN202410042940.0A CN202410042940A CN118078719A CN 118078719 A CN118078719 A CN 118078719A CN 202410042940 A CN202410042940 A CN 202410042940A CN 118078719 A CN118078719 A CN 118078719A
- Authority
- CN
- China
- Prior art keywords
- parts
- wet wipe
- extract
- eyes
- nonionic surfactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- 239000000284 extract Substances 0.000 claims abstract description 36
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 claims abstract description 34
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 20
- 239000003381 stabilizer Substances 0.000 claims abstract description 19
- WRYLYDPHFGVWKC-SNVBAGLBSA-N 4-Terpineol Natural products CC(C)[C@]1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-SNVBAGLBSA-N 0.000 claims abstract description 17
- 230000002335 preservative effect Effects 0.000 claims abstract description 17
- 241000208680 Hamamelis mollis Species 0.000 claims abstract description 16
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 16
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 16
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000003755 preservative agent Substances 0.000 claims abstract description 16
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 16
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 16
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 16
- 229940046009 vitamin E Drugs 0.000 claims abstract description 16
- 239000011709 vitamin E Substances 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229940118846 witch hazel Drugs 0.000 claims abstract description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 11
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical group OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 4
- 244000299461 Theobroma cacao Species 0.000 claims description 4
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 4
- 230000002421 anti-septic effect Effects 0.000 claims description 4
- -1 antiseptic Substances 0.000 claims description 4
- 229960005323 phenoxyethanol Drugs 0.000 claims description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 3
- 229960003237 betaine Drugs 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 238000009736 wetting Methods 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 9
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 7
- 230000037307 sensitive skin Effects 0.000 abstract description 7
- 230000009044 synergistic interaction Effects 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 14
- 238000012360 testing method Methods 0.000 description 12
- 206010015150 Erythema Diseases 0.000 description 7
- 230000001954 sterilising effect Effects 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- 231100000321 erythema Toxicity 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000003889 eye drop Substances 0.000 description 3
- 229940012356 eye drops Drugs 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 241000208690 Hamamelis Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000011056 performance test Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011076 safety test Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 241001128004 Demodex Species 0.000 description 1
- 241000191070 Escherichia coli ATCC 8739 Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 229940125687 antiparasitic agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
The invention relates to the technical field of daily necessities, in particular to a wet tissue composition for eyes as well as a preparation method and application thereof. The wet wipe composition comprises 4-terpineol, sodium hyaluronate, vitamin E, witch hazel extract, nonionic surfactant, oat extract, preservative, stabilizer, and water. The wet tissue composition for eyes can achieve the effects of anti-inflammatory, antibacterial and relieving by the synergistic interaction of 4-terpineol, sodium hyaluronate, vitamin E, witch hazel extract, nonionic surfactant, oat extract, preservative, stabilizer and water, and is suitable for sensitive skin, especially the skin around eyes.
Description
Technical Field
The invention relates to the technical field of daily necessities, in particular to a wet tissue composition for eyes as well as a preparation method and application thereof.
Background
People often contact dust, computer, cell-phone radiation, automobile exhaust, haze and kitchen oil smoke etc. among them harmful substance all can get into eyes, cause uncomfortable such as eyes portion dryness, when the eyes secretion is too much or have the foreign matter, people are used to the hand, water or ordinary paper handkerchief wipe eyes, easily infects the bacterium, appears the inflammation even. Many people then choose to use eye drops. However, after the eye drops are added, the eye drops remain on the skin of eyes, and the eyes are required to be rubbed by paper towels or hands, so that the eyes are polluted. Most of the wet tissues for eyes on the current market aim at daily cleaning and makeup removal demands, but few products consider the demands of relieving and anti-inflammatory, so that it is very necessary to design the wet tissues for eyes with anti-inflammatory, antibacterial and relieving functions.
Disclosure of Invention
In order to solve the technical problems, the invention provides a wet tissue composition for eyes and a preparation method and application thereof.
According to a first aspect of the present invention, there is provided a wet wipe composition for eyes comprising 4-terpineol, sodium hyaluronate, vitamin E, witch hazel extract, nonionic surfactant, oat extract, preservative, stabilizer and water.
In the scheme, the wet tissue composition for eyes comprises 4-terpineol, sodium hyaluronate, vitamin E, witch hazel extract, nonionic surfactant, oat extract, preservative, stabilizer and water, wherein the 4-terpineol has the functions of resisting oxidation, resisting bacteria, expelling parasites and killing mites, is mainly used as an anti-inflammatory agent, an anti-parasitic agent, an anti-tumor agent and a flavoring agent, can be widely used for treating acne, acne rosacea and demodex infection, and is suitable for sensitive skin. Sodium hyaluronate has deep moisturizing effect, and can increase skin elasticity. Vitamin E has antioxidant and protecting effects, and helps to reduce free radical injury. The Hamamelis extract is extracted from bark, branches and leaves of Hamamelis shrub native to North America, has hemostatic and antiinflammatory effects, and can calm skin and reduce redness and swelling. The nonionic surfactant has cleaning effect. The oat extract is a whole plant extract of oat of Gramineae, mainly contains beta-glucan, flavonoid compounds and various antioxidant substances, has excellent anti-aging effect, can smooth fine wrinkles, improves skin texture, and further increases anti-inflammatory and relieving effects. The antiseptic can inhibit microorganism activity, prevent wet towel from spoilage, and maintain product stability. The stabilizing agent maintains the wettability of the wet wipe and helps the skin retain moisture. The wet tissue composition for eyes can achieve the effects of anti-inflammatory, antibacterial and relieving through the synergistic interaction of 4-terpineol, sodium hyaluronate, vitamin E, witch hazel extract, nonionic surfactant, oat extract, preservative, stabilizer and water, and is suitable for sensitive skin, especially skin around eyes.
In order to better achieve the anti-inflammatory, antibacterial and soothing effects, further, the wet tissue composition comprises the following components in parts by weight: 1-2 parts of 4-terpineol, 0.1-1 part of sodium hyaluronate, 0.1-0.3 part of vitamin E, 1-2 parts of witch hazel extract, 1-3 parts of nonionic surfactant, 0.1-1 part of oat extract, 0.1-1 part of preservative, 1-3 parts of stabilizer and 90-95 parts of water.
In order to better achieve the anti-inflammatory, antibacterial and soothing effects, further, the wet tissue composition comprises the following components in parts by weight: 1.5 parts of 4-terpineol, 0.5 part of sodium hyaluronate, 0.2 part of vitamin E, 1.5 parts of witch hazel extract, 2 parts of nonionic surfactant, 0.5 part of oat extract, 0.5 part of preservative, 2 parts of stabilizer and 91.3 parts of water.
Further, the nonionic surfactant is cocoa amidopropyl betaine.
In the scheme, the cocoa amidopropyl betaine serving as the nonionic surfactant has the advantages of cleaning effect, mild property and suitability for sensitive skin.
Further, the preservative is phenoxyethanol.
In the scheme, the phenoxyethanol is used as the preservative, so that the preservative effect can be achieved, and the skin is not stimulated.
Further, the stabilizer is glycerol.
In the scheme, the glycerol keeps the wettability of the wet tissues, helps the skin to keep moisture, and achieves the effect of stabilizing the skin.
According to a second aspect of the present invention, there is also provided a method of preparing the wet wipe composition described above, comprising the steps of: mixing 4-terpineol, sodium hyaluronate, vitamin E, hamamelis mollis extract, nonionic surfactant, herba Avenae Fatuae extract, antiseptic, stabilizer and water.
Further, the temperature of the mixing is 40-60 ℃, preferably 50 ℃.
According to a third aspect of the present invention there is also provided the use of a wet wipe composition as described above in an ophthalmic wet wipe.
Further, the wet wipe composition is applied to a biodegradable nonwoven fabric to ensure uniform wetting, resulting in a wet wipe for the eye.
There are two packaging forms of wet tissues for eyes, the first is to package wet tissues for eyes in a sealed package to maintain the wettability and the ingredient stability thereof. Secondly, the wet tissue composition and the biodegradable non-woven fabric are packaged separately, when the wet tissue composition is needed to be used, the wet tissue composition contained in the package is folded for 3 times, and the package is lightly pressed, so that the wet tissue composition is fully contacted with the biodegradable non-woven fabric; then tearing along the opening, taking out the wet tissue for eyes, winding the wet tissue on the index finger of the right hand, closing the eyes, and cleaning the skin around the eyes.
The technical scheme provided by the invention has the following beneficial effects:
The wet tissue composition for eyes can achieve the effects of resisting inflammation, resisting bacteria and relieving through the mutual synergistic effect of 4-terpineol, sodium hyaluronate, vitamin E, witch hazel extract, nonionic surfactant, oat extract, preservative, stabilizer and water, and is suitable for sensitive skin, especially skin around eyes.
Detailed Description
For the purpose of making the objects, technical solutions and advantages of the present invention more apparent, the technical solutions of the present invention will be clearly and completely described below, and it is apparent that the described embodiments are some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
All the raw materials used in the following examples and comparative examples are commercially available, except for the specific descriptions.
Examples 1 to 5, comparative examples 1 to 2
Examples 1-5 and comparative examples 1-2 each independently provided a wet wipe composition for eyes, which was prepared by the following method, with the raw materials composition shown in table 1 below, in parts by weight: mixing 4-terpineol, sodium hyaluronate, vitamin E, hamamelis mollis extract, nonionic surfactant, herba Avenae Fatuae extract, antiseptic, stabilizer and water at 50deg.C. Wherein the nonionic surfactant is cocoa amide propyl betaine, the preservative is phenoxyethanol, and the stabilizer is glycerol.
TABLE 1
Comparative example 3
This comparative example provides a wet wipe composition for the eye which differs from example 1 in that the same amount of camphor is used instead of 4-terpineol.
The wet wipe composition for eye use of this comparative example was prepared in the same manner as in example 1.
Comparative example 4
This comparative example provides a wet wipe composition for the eye, which differs from example 1 in that the same amount of kuh-seng extract is used instead of witch hazel extract.
The wet wipe composition for eye use of this comparative example was prepared in the same manner as in example 1.
Comparative example 5
This comparative example provides a wet wipe composition for the eye, which differs from example 1 in that the oat extract is replaced with the same amount of honeysuckle extract.
The wet wipe composition for eye use of this comparative example was prepared in the same manner as in example 1.
Experimental example
The wet wipe compositions for eyes prepared in the above examples and comparative examples were subjected to anti-inflammatory, antibacterial, soothing and skin safety tests, and the specific test results are shown in tables 2 to 4 below:
1. Antibacterial performance test: the sterilization effect test is carried out on the wet tissue composition for eyes according to the sterilization technical specification, wherein the sterilization effect of the wet tissue composition for eyes on staphylococcus aureus ATCC6538 and escherichia coli ATCC8739 is tested for 30s, 2min and 5min according to the bacterial quantitative sterilization test of the sterilization technical specification 2.1.1.7; the ophthalmic wet wipe composition was tested for 30s, 2min, 5min sterilization effect on candida albicans ATCC10231 according to the sterilization technical Specification 2.1.1.9 fungus killing test, and the results are shown in tables 2-4.
TABLE 2
TABLE 3 Table 3
TABLE 4 Table 4
2. Relaxation performance test
The test method is as follows:
Subject selection criteria: 200 women aged 20-50 years old, from which sensitive skin, periocular skin had inflammation and had erythema, were divided into 10 groups of 20 persons each, and the ocular wet tissues prepared by using the ocular wet tissue compositions of examples 1-5 and comparative examples 1-5 were tested, respectively, and were used twice daily, once in the morning, and once before sleep; the subject has no external application, oral administration or injection of other products which can affect the test for nearly 1 month, including skin care products with effects of relieving, repairing and the like, and the products cannot be used during the test; periocular sites have not been subjected to skin treatments, cosmetics, and other tests that may affect the results.
The testing method comprises the following steps: subjects participated in the test, and a cross-polarized photograph of Visia-CR taken images was selected and isolated to obtain erythema photographs. By means of the photo, erythema, inflammatory injury, telangiectasia and the like of the lower layer of the skin can be observed, so that whether the cosmetics can irritate the skin or have a soothing effect on the skin can be judged. And calculating the skin erythema area change of the selected area by using IPP software, and averaging the two sides. The decrease rates of the areas of erythema after 15 days and 30 days were measured for each subject in each group, and the average value was calculated to obtain the decrease rates of the areas of erythema after 15 days and 30 days for each group of subjects, respectively, and the measurement results are shown in table 5 below.
TABLE 5
3. Skin safety test
The test method is patch test, 300 adults are selected as test objects, the ages are between 20 and 25 years, the interior of the arm forearm is selected, and the skin state is observed after 24 hours. The test results are shown in table 6 below.
TABLE 6
From the experimental results, the wet tissue composition for eyes can achieve the effects of resisting inflammation, resisting bacteria and relieving through the synergistic interaction of 4-terpineol, sodium hyaluronate, vitamin E, witch hazel extract, nonionic surfactant, oat extract, preservative, stabilizer and water, and is suitable for sensitive skin, especially skin around eyes.
Finally, it should be noted that: the above embodiments are only for illustrating the technical solution of the present invention, and are not limiting; although the invention has been described in detail with reference to the foregoing embodiments, it will be understood by those of ordinary skill in the art that: the technical scheme described in the foregoing embodiments can be modified or some technical features thereof can be replaced by equivalents; such modifications and substitutions do not depart from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims (10)
1. A wet wipe composition for eyes, comprising 4-terpineol, sodium hyaluronate, vitamin E, witch hazel extract, nonionic surfactant, oat extract, preservative, stabilizer and water.
2. The wet wipe composition of claim 1 wherein the wet wipe composition comprises, in parts by weight: 1-2 parts of 4-terpineol, 0.1-1 part of sodium hyaluronate, 0.1-0.3 part of vitamin E, 1-2 parts of witch hazel extract, 1-3 parts of nonionic surfactant, 0.1-1 part of oat extract, 0.1-1 part of preservative, 1-3 parts of stabilizer and 90-95 parts of water.
3. The wet wipe composition of claim 2 wherein the wet wipe composition comprises, in parts by weight: 1.5 parts of 4-terpineol, 0.5 part of sodium hyaluronate, 0.2 part of vitamin E, 1.5 parts of witch hazel extract, 2 parts of nonionic surfactant, 0.5 part of oat extract, 0.5 part of preservative, 2 parts of stabilizer and 91.3 parts of water.
4. The wet wipe composition of claim 1 wherein the nonionic surfactant is cocoa amidopropyl betaine.
5. The wet wipe composition of claim 1 wherein the preservative is phenoxyethanol.
6. The wet wipe composition of claim 1 wherein the stabilizing agent is glycerin.
7. A method of preparing a wet wipe composition according to any one of claims 1-6, comprising the steps of: mixing 4-terpineol, sodium hyaluronate, vitamin E, hamamelis mollis extract, nonionic surfactant, herba Avenae Fatuae extract, antiseptic, stabilizer and water.
8. The preparation method according to claim 7, wherein the temperature of the mixing is 40-60 ℃, preferably 50 ℃.
9. Use of the wet wipe composition of any one of claims 1-6 on an ophthalmic wet wipe.
10. The use according to claim 9, characterized in that the wet wipe composition is applied to a biodegradable nonwoven ensuring uniform wetting to obtain a wet wipe for the eye.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410042940.0A CN118078719A (en) | 2024-01-11 | 2024-01-11 | Wet tissue composition for eyes as well as preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410042940.0A CN118078719A (en) | 2024-01-11 | 2024-01-11 | Wet tissue composition for eyes as well as preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN118078719A true CN118078719A (en) | 2024-05-28 |
Family
ID=91143127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410042940.0A Pending CN118078719A (en) | 2024-01-11 | 2024-01-11 | Wet tissue composition for eyes as well as preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN118078719A (en) |
-
2024
- 2024-01-11 CN CN202410042940.0A patent/CN118078719A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20070094958A (en) | Non-irritating compositions containing zinc salts | |
| KR20150102578A (en) | Antibiotic wet tissue, and manufacturing method thereof | |
| CN108542870B (en) | Mild soothing infant face cream | |
| CN111110577B (en) | Mild mite-removing itching-relieving shower gel and preparation method thereof | |
| CN113975197B (en) | Composition containing sodium polyglutamate and dressing applied by composition | |
| CN110585030A (en) | High-molecular gel wrinkle-removing eye mask and preparation method thereof | |
| CN108186403A (en) | A kind of impregnated wipe and preparation method thereof | |
| CN111249217A (en) | Cleansing liquid for adjusting skin micro-ecological balance and preparation method thereof | |
| CN110573136B (en) | Cosmetic composition for improving hair moisture retention | |
| JP2023155497A (en) | topical skin care compositions | |
| CN108014032A (en) | A kind of hip pad wet tissue and preparation method thereof | |
| WO2002076479A1 (en) | Composition for treating acne vulgaris and fabrication method | |
| CN108125797A (en) | A kind of hand mouth wet tissue and preparation method thereof | |
| CN109620758B (en) | Double-layer scalp care composition and preparation method thereof | |
| CN118078719A (en) | Wet tissue composition for eyes as well as preparation method and application thereof | |
| CN115177559B (en) | Mild and non-irritating composition for infants, washing and caring product and preparation method thereof | |
| ES2841940T3 (en) | Complexes and compositions for the treatment of ophthalmic and dermatological diseases | |
| KR102342731B1 (en) | Composition For Eyelid or Periocular Region Washing and Pad Comprising Thesame | |
| KR102141128B1 (en) | composition for eyelid or periocular region washing and pad comprising thesame | |
| KR20190042164A (en) | Composition and method for non-atiseptic wet tissues containing the ingredient to inhibit microbial propagation | |
| CN112156023A (en) | Makeup removing gel and preparation method thereof | |
| DE102008040977A1 (en) | Use of cleansing milk for treating or caring and/or prophylaxis of skin damage on foot and for disinfecting of foot | |
| CN112168759A (en) | Infant skin lotion and preparation method thereof | |
| WO2001078659A1 (en) | Milky lotions, cosmetic preparations, skin cleansers and skin cleansing articles | |
| KR20150036913A (en) | Semi-transparent composition for scalp or hair |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |